Facial Chromoblastomycosis with Visceral Involvement in Form of Extensive Abdominal Lymphadenopathy – A Case Report and Literature review.
DOI:
https://doi.org/10.37762/jgmds.13-4.978Keywords:
Chromoblastomycosis, Antifungal Agents, LymphadenopathyAbstract
OBJECTIVES
Chromoblastomycosis is a chronic granulomatous infection caused by a group of dematiaceous fungi and most commonly affects the lower extremities of individuals exposed to colonised mud or wood, such as agriculturists and ecotourists. It is most commonly limited to the skin and subcutaneous tissue but can be locally aggressive, leading to local lymphadenopathy, osteomyelitis and lytic bony lesions. Treatment modalities include surgical excision of the chromoblastomycosis lesion, oral antifungal agents or physical therapy, with the decision depending upon the size and severity of the lesion.
CASE
A 19-year-old male farmer presented to us with an erythematous plaque on his right cheek along with generalised jaundice and pruritus. The skin lesion was diagnosed as a chromoblastomycosis lesion on histopathological evaluation. Workup of his jaundice revealed extensive abdominal lymphadenopathy causing a compressive effect on the common hepatic duct. Histopathology of the lymph node taken from the porta hepatis confirmed systemic extension of fungal infection. He was treated with oral antifungals in combination with debulking abdominal surgery for his extensive abdominal lymphadenopathy causing obstructive jaundice. The patient responded well, with his liver function tests improving, and abdominal lymphadenopathy and facial lesion decreasing in size on follow-up.
CONCLUSION
The key learning points of this case report are that chromoblastomycosis, in addition to local invasion and lymphadenopathy, can cause visceral involvement as well, even though it is rare. In these cases, spread can be via lymphatic or hematogenous routes. In cases like ours, where visceral involvement was evident in the form of extensive abdominal lymphadenopathy, debulking surgery for symptomatic relief can be considered as part of the treatment regimen. Even in cases of chromoblastomycosis with visceral involvement, the role of oral antifungals remains justified, as both the chromoblastomycosis lesion and visceral features responded to antifungal therapy in our case.
Downloads
References
World Health Organization. Chromoblastomycosis [Internet]. Geneva: World Health Organization; 2023 Nov 15 [cited 2024 Aug 18]. Available from: https://www.who.int/news-room/fact-sheets/detail/chromoblastomycosis
Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2009;47(1):3-15. doi:10.1080/13693780802538001. PMID: 19085206 DOI: https://doi.org/10.1080/13693780802538001
Queiroz-Telles F, de Hoog S, Santos DWCL, Salgado CG, Vicente VA, Bonifaz A, et al. Chromoblastomycosis. Clin Microbiol Rev. 2017;30(1):233-276. doi:10.1128/CMR.00032-16. PMID: 27856522; PMCID: PMC5217794 DOI: https://doi.org/10.1128/CMR.00032-16
Kurien G, Sugumar K, Sathe NC, Chandran V. Chromoblastomycosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [updated 2024 Mar 1]
Queiróz AJR, Pereira Domingos F, Antônio JR. Chromoblastomycosis: clinical experience and review of literature. Int J Dermatol. 2018;57(11):1351-1355. doi:10.1111/ijd.14185. PMID: 30113072 DOI: https://doi.org/10.1111/ijd.14185
Queiroz-Telles F, Nucci M, Colombo AL, Tobón A, Restrepo A. Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment. Med Mycol. 2011;49(3):225-236. doi:10.3109/13693786.2010.539631. PMID: 21128710 DOI: https://doi.org/10.3109/13693786.2010.539631
Singal A, Grover C, editors. Comprehensive approach to infections in dermatology. New Delhi: Jaypee Brothers Medical Publishers; 2015. ISBN: 978-93-5152-748-0
Agarwal R, Singh G, Ghosh A, Verma KK, Pandey M, Xess I. Chromoblastomycosis in India: review of 169 cases. PLoS Negl Trop Dis. 2017;11(8). doi:10.1371/journal.pntd.0005534. PMID: 28771470; PMCID: PMC5542425 DOI: https://doi.org/10.1371/journal.pntd.0005534
Lan Y, Lu S, Zhang J. Retinoid combined with photodynamic therapy against hyperkeratotic chromoblastomycosis: a case report and literature review. Mycoses. 2021;64(1):18-23. doi:10.1111/myc.13190. PMID: 32989774 DOI: https://doi.org/10.1111/myc.13190
Falgout L, Hilton D. Clinical presentation and management of chromoblastomycosis: a case report and review. Med Mycol Case Rep. 2023;41:8-10. doi:10.1016/j.mmcr.2023.05.004. PMID: 37288321; PMCID: PMC10242489 DOI: https://doi.org/10.1016/j.mmcr.2023.05.004
Fukushiro R. Chromomycosis in Japan. Int J Dermatol. 1983;22(4):221-229. doi:10.1111/j.1365-4362.1983.tb03371.x. PMID: 6345416 DOI: https://doi.org/10.1111/j.1365-4362.1983.tb03371.x
Seyedmousavi S, Netea MG, Mouton JW, Melchers WJG, Verweij PE, de Hoog GS. Black yeasts and their filamentous relatives: principles of pathogenesis and host defense. Clin Microbiol Rev. 2014;27(3):527-542. doi:10.1128/CMR.00093-13. PMID: 24982320; PMCID: PMC4135901 DOI: https://doi.org/10.1128/CMR.00093-13
Nosanchuk JD, Casadevall A. The contribution of melanin to microbial pathogenesis. Cell Microbiol. 2003;5(4):203-223. doi:10.1046/j.1462-5814.2003.00268.x. PMID: 12675679 DOI: https://doi.org/10.1046/j.1462-5814.2003.00268.x
Qiu Y, Zhang J, Tang Y, Zhong X, Deng J. Case report: fever-pneumonia-lymphadenectasis-osteolytic-subcutaneous nodule: disseminated chromoblastomycosis caused by Phialophora. J Infect Chemother. 2019;25(12):1031-1036. doi:10.1016/j.jiac.2019.05.002. PMID: 31229375 DOI: https://doi.org/10.1016/j.jiac.2019.05.002
Abliz P, Fukushima K, Takizawa K, Nishimura K. Specific oligonucleotide primers for identification of Cladophialophora carrionii, a causative agent of chromoblastomycosis. J Clin Microbiol. 2004;42(1):404-407. doi:10.1128/JCM.42.1.404-407.2004. PMID: 14715791; PMCID: PMC321686 DOI: https://doi.org/10.1128/JCM.42.1.404-407.2004
de Andrade TS, Cury AE, de Castro LGM, Hirata MH, Hirata RDC. Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis. Diagn Microbiol Infect Dis. 2007;57(3):267-272. doi:10.1016/j.diagmicrobio.2006.08.024. PMID: 17338941 DOI: https://doi.org/10.1016/j.diagmicrobio.2006.08.024
Kumarasinghe SPW, Kumarasinghe MP. Itraconazole pulse therapy in chromoblastomycosis. Eur J Dermatol. 2000;10(3):220-222. PMID: 10725823
Tamura K, Matsuyama T, Yahagi E, Kojima T, Akasaka E, Kondo A, et al. A case of chromomycosis treated by surgical therapy combined with preceded oral administration of terbinafine to reduce the size of the lesion. Tokai J Exp Clin Med. 2012;37(1):6-10. PMID: 22488556
Khan S, Khan M, Khan F, Ahmad Z, Zia-Ur-Rehman A. A rare case of chromoblastomycosis in a 12-year-old boy. J Pak Med Assoc. 2019;69(9):1390-1393. PMID: 31511733
Chaudhry ZS, Ghias A, Shaheen E, Irfan K, Aman S. Verrucous and ulcerovagitant facial chromo-blastomycosis with nasal bridge destruction, cleaving upper lip deformity and exuberant eyelid squamous cell carcinoma—rare debilitating sequel of facial chromoblastomycosis in a non-endemic region: a case report. J Pak Assoc Dermatol. 2023;33(2):764-769. doi:10.66344/jpad.33.2.2023.2154 DOI: https://doi.org/10.66344/jpad.v33i2.2154
Gopal KVT, Ramani TV, Panda S, Laxmi PVBR. Disseminated chromoblastomycosis: diffuse truncal involvement with hematogenous spread. Int J Health Allied Sci. 2012;1(3):194-196. doi:10.4103/2278-344X.105087 DOI: https://doi.org/10.4103/2278-344X.105087
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Aliena Badshah, Adnan Yousaf, Ahmed Irtaza, Muqsit Ali Shaukat
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
